The laboratory behind ingredients and supplements
We are the division that develops bioactive ingredients and documents what they do: the process that produces them and the cell models that say whether they work. Both in the same laboratory.
Tell us about your projectA laboratory that manufactures, not only one that studies
BiCT was founded in 2009 as a bioindustry start-up, with a simple idea: give client companies a competitive research and development system without having to build one in house. Today we are more than twenty people between employees and collaborators, on a 3,600-square-metre site in the Lodi area.
That floor area matters more than it sounds. The research laboratory and the production area are the same place, which means technology transfer is not a handover between two companies with two quality systems and two contacts: it is a move of a few dozen metres, made by the same people who developed the process.
What sets us apart
Two trades under one roof
We know how to produce an ingredient — extraction, synthesis, fermentation — and how to demonstrate what it does. Whoever only runs tests cannot touch the process when the data does not add up; whoever only runs process cannot document the effect.
Twelve biological areas
Gastrointestinal, metabolic and cardiovascular, dermatological, neurological, musculoskeletal, respiratory, oral, urological, vaginal and immune system, plus farm animals and pets. Each area with its own models and endpoints.
Projects with industrial and clinical partners
PRO-MIND, SmartNutriHealth2, Probiotiká, SCIDA, InnoFeed: five projects from the probiotic strain to the finished formulation, from the human supplement to functional feed.
Equipment
The same instruments as the Bioindustry division, plus the cell models that document the effect.
| Fermentation | Applikon and Biostream fermenters, from shake flasks up to 100 litres, and up to 50 m³ with our manufacturing partners |
| Downstream | ÄKTA chromatography systems, tangential flow filtration, ultrafiltration and diafiltration, centrifugation and homogenisation |
| Formulation | Pilot spray dryer, freeze-drying cycles, stability studies at controlled temperatures |
| Analytics | Preparative HPLC and UPLC, GC with mass spectrometry and headspace, SEC, SDS-PAGE, spectrophotometers and titrators; molecular biology and storage at −80 °C |
| Cell culture | Sterile laminar flow hoods, standard, CO₂ and humidity-controlled incubators |
| Automation | A.L.EX, the robotic platform for high throughput screening, up to 40,000 samples a day in 384-well plates |
Who you will be working with
The people who follow this division’s projects.
- Monica Marzagalli, PhD — Business Unit Manager Pharmaceutical biotechnologist, PhD in Endocrine and Metabolic Sciences; leads the Nutraceuticals and Cosmetics division.
- Silvia Rapacioli — General Manager
- Fiorella Greco — Quality and Regulatory Affairs Manager
- Chiara Verri — commercial contact for Nutraceuticals and Cosmetics
Tell us how far you have got
An ingredient to valorise, a formulation to strengthen, an ingredient that does not exist yet: tell us where you are and we will tell you what it takes.
Tell us about your project